Learning Objectives
- Review current evidence and new therapies for the treatment of AdvSM with a focus on SM-AHN.
- Evaluate key patient-specific factors (e.g., tumor characteristics, comorbidities, genetic markers, and performance status) that influence treatment selection in patients with SM-AHN.
- Apply evidence-based strategies to optimize individualized care with patient cases.
Moderators
Speakers
Videos
Podcasts
This program has been made possible through unrestricted support from GSK.